OncLive: Dr. Mesa on recent data with momelotinib in MPNs and myelofibrosis
July 20, 2020
Ruben Mesa, MD, director of the Mays Cancer Center, discusses recent data with momelotinib in myelofibrosis. Read and watch the story.
Study hints at novel therapeutic target for Ewing sarcoma
July 16, 2020
New insights into Ewing sarcoma, an aggressive childhood cancer, were published July 15 in the prestigious journal Nature.
Finding published in Nature hints at novel therapeutic target for Ewing sarcoma
July 16, 2020
New insights into Ewing sarcoma, an aggressive childhood cancer, were published July 15 in the prestigious journal Nature. Researchers from the Long School of Medicine at The University of Texas Health Science Center at San Antonio contributed to the study. Ewing sarcoma is a bone and soft tissue cancer that primarily affects children and adolescents. […]
The Cancer Letter: Ruben Mesa: Facing a dramatic COVID-19 spike in San Antonio
July 13, 2020
Dr. Ruben Mesa, Mays Cancer Center Director, contributes to The Cancer Letter’s ongoing coverage of COVID-19’s impact on oncology. Read the story.
ABC 12 TV Miami: Cork tree bark to fight cancer
July 10, 2020
ABC 12 TV in Miami, Fla., aired the Ivanhoe Broadcast News story about research being conducted by Pratap Kumar, PhD, Department of Molecular Medicine, and Darpan Patel, PhD, associate professor of research in the School of Nursing. The researchers decided to test cork tree bark extract, also called Nexrutine, to fight dangerous body inflammation, which […]
San Antonio Magazine: What to expect after COVID-19
July 10, 2020
Dr. Ruben Mesa, Mays Cancer Center director, and Dr. Ramon Cancino, Primary Care Center director, weigh in on how the pandemic will affect the future of education and health care. Read the story.